GLP-1 Receptor Agonists Across the Cardiovascular-Kidney-Metabolic Continuum: From Evidence to Practice: PSSNY Winter Conference

January 25, 2026

Target Audience

All pharmacists

Learning Objectives

 

At the completion of the activity, the participant will be able to:

Explain the role of GLP-1 receptor agonists across the cardiovascular-kidney-metabolic continuum, including diabetes, obesity, cardiovascular disease, and chronic kidney disease.
Evaluate key clinical trials informing the cardiovascular and kidney benefits of GLP-1 receptor agonists.
Apply evidence-based strategies for initiating, titrating, and monitoring GLP-1 receptor agonists in patients across the CKM spectrum.
Implement practical approaches to prevent and manage common GLP-1 receptor agonist–associated adverse effects in clinical practice.

Course summary
Available credit: 
  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Course opens: 
12/18/2024
Course expires: 
11/19/2027
Event starts: 
01/25/2026 - 9:00am EST
Event ends: 
01/25/2026 - 10:00am EST
Cost:
$0.00
Add to calendar: 
Rating: 
0
NY
United States

Zoom Link will be emailed to you.

 

Presenter: Lavinia Salama PharmD, BCACP, BCGP, BC-ADM, CDCES

Assistant Professor Pharmacy Practice at Arnold and Marie Schwartz College of Pharmacy

 

ACPE UAN #  0042-9999-25-066-L01-P

Available Credit

  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Price

Cost:
$0.00
Please login or register to take this course.